391 related items for PubMed ID: 11793034
1. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
[Abstract] [Full Text] [Related]
2. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[Abstract] [Full Text] [Related]
3. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
[Abstract] [Full Text] [Related]
4. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
Cheung CY, Wong KM, Chan HW, Liu YL, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Li CS.
Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
[Abstract] [Full Text] [Related]
5. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
Krämer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuño J, Sester U, Kunzendorf U, Dietl KH, Bonomini V, Rigotti P, Ronco C, Tabernero JM, Rivero M, Banas B, Mühlbacher F, Arias M, Montagnino G, European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.
Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740
[Abstract] [Full Text] [Related]
6. Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis.
Cheung CY, Chan HW, Liu YL, Chau KF, Li CS.
Nephrology (Carlton); 2009 Dec; 14(8):758-63. PubMed ID: 20025685
[Abstract] [Full Text] [Related]
7. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[Abstract] [Full Text] [Related]
8. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[Abstract] [Full Text] [Related]
9. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[Abstract] [Full Text] [Related]
10. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
Alghamdi S, Nabi Z, Skolnik E, Alkorbi L, Albaqumi M.
Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
[Abstract] [Full Text] [Related]
11. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[Abstract] [Full Text] [Related]
12. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
Cheung CY, Liu YL, Wong KM, Chan HW, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Shek CC, Li CS.
Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
[Abstract] [Full Text] [Related]
13. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
Irish W, Sherrill B, Brennan DC, Lowell J, Schnitzler M.
Transplantation; 2003 Dec 27; 76(12):1686-90. PubMed ID: 14688516
[Abstract] [Full Text] [Related]
14. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
[Abstract] [Full Text] [Related]
15. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
[Abstract] [Full Text] [Related]
16. Rejection after simultaneous pancreas-kidney transplantation.
Arbogast H, Malaise J, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W, Euro-SPK Study Group.
Nephrol Dial Transplant; 2005 May 27; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
[Abstract] [Full Text] [Related]
17. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
Chamienia A, Biedunkiewicz B, Król E, Debska-Slizień A, Rutkowski B.
Transplant Proc; 2006 May 27; 38(1):81-5. PubMed ID: 16504670
[Abstract] [Full Text] [Related]
18. Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis.
Murphy GJ, Waller JR, Sandford RS, Furness PN, Nicholson ML.
Br J Surg; 2003 Jun 27; 90(6):680-6. PubMed ID: 12808614
[Abstract] [Full Text] [Related]
19. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
White M, Haddad H, Leblanc MH, Giannetti N, Pflugfelder P, Davies R, Isaac D, Burton J, Chan M, Azevedo E, Howlett J, Ignaszewski A, Busque S, Cantarovich M, Ferguson R, Genest J, Ross H.
J Heart Lung Transplant; 2005 Jul 27; 24(7):798-809. PubMed ID: 15982605
[Abstract] [Full Text] [Related]
20. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T, CRAF Study Group.
Clin Transplant; 2005 Oct 27; 19(5):573-80. PubMed ID: 16146546
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
